MedPath

In-Use Test With a Cosmetic Product to Treat Pruritus

Not Applicable
Completed
Conditions
Pruritus
Interventions
Other: WO 3308 cosmetic product for topical use
Registration Number
NCT03477058
Lead Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Brief Summary

The aim of the study is to evaluate the cosmetic features of the product WO 3308 by means of a questionnaire in an interview situation after two weeks of product treatment, giving special consideration to the cosmetic performance, efficacy and skin compatibility and with special focus on the reduction of pruritus. Additionally the tolerance will be evaluated by a dermatologist.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
55
Inclusion Criteria
  • age: ≥ 18 years
  • sex: approx. 25% to 50% male and 50% to 75% female
  • with acute pruritus (lasts less than 6 weeks) or chronic pruritus (lasts longer than 6 weeks): max. 50% with acute pruritus and at least 50% with chronic pruritus
Exclusion Criteria
  • any deviation from the above-mentioned criteria
  • known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
  • topical medication in the test area within 1 month prior to study start
  • systemic medication with antibiotics within 2 weeks prior to starting of the study
  • change in the medication with anti-inflammatory agents within 2 weeks prior to starting the study
  • systemic medication with immunomodulators (immunsuppressive drugs in the course of a transplantation) and/or chemotherapeutic agents within 4 weeks prior to starting the study
  • neurodermatitis (atopic dermatitis)
  • pregnancy and period of breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
WO 3308 cosmetic product for topical useWO 3308 cosmetic product for topical useWO 3308 is used to treat acute or chronic pruritus
Primary Outcome Measures
NameTimeMethod
Cosmetic Features of the Test Productbaseline, two weeks

Change from baseline for the cosmetic features (spreadability, absorbtion, skin feeling after application, fragrance) of the test product by the means of an interview-based questionnaire

Reduction of Pruritusbaseline, two weeks

Change from baseline reduction of pruritus at two weeks by the means of an interview-based questionnaire

Secondary Outcome Measures
NameTimeMethod
Tolerance of the Test Product on the skinbaseline, two weeks

Change from baseline at two weeks by the means of a dermatological and subjective assessment of skin tolerance on arms and legs

Trial Locations

Locations (1)

SIT Skin Investigation and Technology Hamburg GmbH

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath